Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Renal denervation linked to significant BP reductions after 3 years | ACC.22 in Pictures
Thursday, April 7, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Renal denervation linked to significant blood pressure reductions after 3 years

An updated look at patients treated with Medtronic's renal denervation system was presented at ACC.22 and simultaneously published in The Lancet. 

READ MORE >
The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.
Share on Twitter Share on Facebook Share on Linkedin

Renal denervation linked to significant blood pressure reductions after 3 years

Share on Twitter Share on Facebook Share on Linkedin
The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.
An updated look at patients treated with Medtronic's renal denervation system was presented at ACC.22 and simultaneously published in The Lancet. 
READ MORE >

Photo Gallery: ACC 2022 in pictures

Click through a wide variety of snapshots from ACC.22 in Washington, D.C. 

READ MORE >
The mitral valve visualized by a a GE NuVision 4D intra-cardiac echo (ICE) catheter a life-like surgical rendering technology on the Vivid E95 cardiac ultrasound system. The catheter was co-developed with Biosense Webster to perform EP procedures. It also can be used in place of TEE in structural heart procedures to eliminate the need for an interventional echocardiography.  #ACC22
Share on Twitter Share on Facebook Share on Linkedin

Photo Gallery: ACC 2022 in pictures

Share on Twitter Share on Facebook Share on Linkedin
The mitral valve visualized by a a GE NuVision 4D intra-cardiac echo (ICE) catheter a life-like surgical rendering technology on the Vivid E95 cardiac ultrasound system. The catheter was co-developed with Biosense Webster to perform EP procedures. It also can be used in place of TEE in structural heart procedures to eliminate the need for an interventional echocardiography.  #ACC22
Click through a wide variety of snapshots from ACC.22 in Washington, D.C. 
READ MORE >

Featured Articles

Abbott’s single-chamber leadless pacemaker gains FDA approval

Another single-chamber leadless pacemaker has officially hit the market. 

READ MORE >
Abbott’s Aveir single-chamber (VR) leadless pacemaker FDA approval for treating patients with bradycardia. Image courtesy of Abbott.
Share on Twitter Share on Facebook Share on Linkedin

Abbott’s single-chamber leadless pacemaker gains FDA approval

Share on Twitter Share on Facebook Share on Linkedin
Abbott’s Aveir single-chamber (VR) leadless pacemaker FDA approval for treating patients with bradycardia. Image courtesy of Abbott.
Another single-chamber leadless pacemaker has officially hit the market. 
READ MORE >

AI model able to ID early signs of type 2 diabetes on imaging results

The authors hope their findings could lead to earlier diagnoses and improvements in patient care. 

READ MORE >
CT pancreas diabetes.jpg
Share on Twitter Share on Facebook Share on Linkedin

AI model able to ID early signs of type 2 diabetes on imaging results

Share on Twitter Share on Facebook Share on Linkedin
CT pancreas diabetes.jpg
The authors hope their findings could lead to earlier diagnoses and improvements in patient care. 
READ MORE >

PCI vs. CABG for left main disease: Key takeaways from a new meta-analysis

Researchers explored data from five different randomized controlled trials, publishing their analysis in the American Journal of Cardiology.

READ MORE >
While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common. Top 10 reasons for readmission after heart transplant.
Share on Twitter Share on Facebook Share on Linkedin

PCI vs. CABG for left main disease: Key takeaways from a new meta-analysis

Share on Twitter Share on Facebook Share on Linkedin
While a vast majority of heart transplants in the United States are successful, unplanned hospitalizations after the procedures are still incredibly common. Top 10 reasons for readmission after heart transplant.
Researchers explored data from five different randomized controlled trials, publishing their analysis in the American Journal of Cardiology.
READ MORE >

In Other News

UnitedHealth, Change Healthcare extend merger agreement, adding $650M breakup fee if DOJ suit prevails

The two companies said the agreement reflects their commitment to combining and desire to fight the Department of Justice's "meritless legal challenge to this merger." 

READ MORE >
A cardiology practice in Florida and several of its cardiologists have agreed to pay $2 million to resolve allegations that they violated the False Claims Act and committed fraud. As a part of the agreement, there has been no determination of liability.
Share on Twitter Share on Facebook Share on Linkedin

UnitedHealth, Change Healthcare extend merger agreement, adding $650M breakup fee if DOJ suit prevails

Share on Twitter Share on Facebook Share on Linkedin
A cardiology practice in Florida and several of its cardiologists have agreed to pay $2 million to resolve allegations that they violated the False Claims Act and committed fraud. As a part of the agreement, there has been no determination of liability.
The two companies said the agreement reflects their commitment to combining and desire to fight the Department of Justice's "meritless legal challenge to this merger." 
READ MORE >

Patients' T-shirt size an accurate measurement for CT dose reference levels

Experts suggest that their findings indicate dose reference levels could be shirt size specific in the not so distant future, according to a study published in the European Journal of Radiology. 

READ MORE >
These findings underscore the need for better implementation of shared decision-making (SDM) models, as well as more thorough counseling documentation, as low-dose CT (LDCT) lung screen coverage is dependent on these factors, experts suggested.
Share on Twitter Share on Facebook Share on Linkedin

Patients' T-shirt size an accurate measurement for CT dose reference levels

Share on Twitter Share on Facebook Share on Linkedin
These findings underscore the need for better implementation of shared decision-making (SDM) models, as well as more thorough counseling documentation, as low-dose CT (LDCT) lung screen coverage is dependent on these factors, experts suggested.
Experts suggest that their findings indicate dose reference levels could be shirt size specific in the not so distant future, according to a study published in the European Journal of Radiology. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

New payment model on the way | Major recalls could impact care | Policy changes for breakthrough devices
FDA warns public after patient death | Medtronic recalls heart devices | 'Compelling' new PE data | Pushing for TAVR changes
News Alert: Medtronic recalls thousands of surgical devices
New IVL tech overcomes previous limitations | 3-year SMART data looks at TAVR outcomes | Artivion acquires Endospan for $135M
FDA approves next-gen mitral valve | Doctors are first in world to use new TAVR technique | Preventing a common complication
Key updates in PFA & beyond | More good IVL news for Boston Scientific | FDA approves new hypertension drug
Cardiologists scramble to prepare for new policy | Boston Scientific invests $1.5B in TAVR developer | FDA clears cath lab tech

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …5
    • Page 6
    • Page 7
    • Page 8
    • Current page 9
    • Page 10
    • Page 11
    • Page 12
    • Page 13 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme